Nautilus Neurosciences, Inc. — Form D/A
Nautilus Neurosciences, Inc. of BRIDGEWATER, NJ, a company, filed a Form D amendment with the SEC on 2010-01-27. The offering totals $14.5M, of which $14.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-01-27
- Form: D/A
- Accession: 0001140361-10-002830
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $14.5M
- Amount sold: $14.5M
- Minimum investment: $40K
- Investors: 10
- Date of first sale: 2009-11-23
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-136775
Issuer
- Name: Nautilus Neurosciences, Inc.
- CIK: 0001478193
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 1200 ROUTE 22 EAST, BRIDGEWATER, NJ, 08807
- Phone: 908-437-1320
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Geoffrey S Raker | Director | NEW YORK, NY |
| Frank V Sica | Director | New York, NY |
| James L Fares | Director | Bridgewater, NJ |
| James L Fares | Executive Officer | Bridgewater, NJ |
| Eric J Liebler | Director | Bridgewater, NJ |
| Eric J Liebler | Executive Officer | Bridgewater, NJ |
| William R Maichle | Executive Officer | Bridgewater, NJ |
| Douglas M Karp | Director | New York, NY |
| Neil R Milano | Executive Officer | Bridgewater, NJ |
| William V Maichle | Executive Officer | Bridgewater, NJ |
| David V Azad | Director | Stamford, CT |
| Zubeen V Shroff | Director | Stamford, CT |
| John V Groom | Director | Hitchin, Herts, X0 |
Other filings by this issuer (3)
More